Abbott Laboratories Stock News

Portland Global Advisors LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT) by 13.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 8,108 shares of the healthcare product makers stock after purchasing an additional 987 shares during the period. Portland Global Advisors LLCs holdings in []

Jacobs & Co. CA grew its position in Abbott Laboratories (NYSE:ABT) by 0.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,726 shares of the healthcare product makers stock after purchasing an additional 166 shares during the period. Jacobs & Co. CAs []

WestHill Financial Advisors Inc. bought a new stake in Abbott Laboratories (NYSE:ABT) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,447 shares of the healthcare product makers stock, valued at approximately $289,000. Several other hedge funds have also bought and sold shares []

The "Organic Baby Food Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product (Prepared Baby Food, Dried Baby Food, Infant Milk Formula, Others (Biscuits Puffs and Snacks)); Distribution Channel (Supermarket, Hypermarket, Convenience Stores, Online, Other Distribution

The Oncology Molecular Diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell

We've just hit the best time of the year to roll out one of our most potent dividend “hacks.”

Beacon Financial Group boosted its holdings in Abbott Laboratories (NYSE:ABT) by 8.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,143 shares of the healthcare product maker’s stock after buying an additional 1,021 shares during the quarter. Beacon Financial Group’s holdings in Abbott […]

Kiplinger Investing publishes opportune source-lists for investors online. Two recent billionaires stock-lists by Dan Burrows were published 6/1/21 and 9/9/21. 20 of the 37 billionaire-held stocks pay

The ASEAN and North Asian Point of Care/Rapid Diagnostics Market study analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porter''s Five Forces Analysis. This research report encompasses

CNBC's Meg Tirrell joins 'Squawk Box' to report on the increased demand for Covid-19 tests ahead of the Thanksgiving holiday.

BFT Financial Group LLC reduced its position in shares of Abbott Laboratories (NYSE:ABT) by 2.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 5,186 shares of the healthcare product makers stock after selling 148 shares during the period. BFT Financial Group LLCs holdings in Abbott Laboratories were worth $613,000 as of its most recent []

Altfest L J & Co. Inc. trimmed its stake in Abbott Laboratories (NYSE:ABT) by 7.7% during the 3rd quarter, HoldingsChannel reports. The fund owned 14,009 shares of the healthcare product makers stock after selling 1,173 shares during the quarter. Altfest L J & Co. Inc.s holdings in Abbott Laboratories were worth $1,655,000 as of its []

BIMI International Medical Inc. (BIMI) with the stream of -9.26% also noticed, India Abbott Laboratories (ABT) encountered a rapid change of -0.63% in the last hour of Fridays trading session. The post Sizzling Stock Alert: BIMI International Medical Inc. (NASDAQ:BIMI), Abbott Laboratories (NYSE:ABT) appeared first on Stocks Equity .

Grassi Investment Management boosted its position in shares of Abbott Laboratories (NYSE:ABT) by 0.5% during the third quarter, Holdings Channel.com reports. The fund owned 113,090 shares of the healthcare product makers stock after acquiring an additional 525 shares during the quarter. Abbott Laboratories accounts for 1.5% of Grassi Investment Managements investment portfolio, making the stock []